HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
Analyst Perspectives | Average price target of $389, ranging from $355 to $420, reflects confidence in HCA's ability to navigate industry challenges and capitalize on opportunities |
Strategic Initiatives | Delve into HCA's AI-driven efficiency improvements and accretive capital strategy, positioning the company for sustainable growth and market share gains |
Financial Resilience | HCA's robust performance amid challenges, with revenue growth of 8.7% and EBITDA of $13.86 billion, showcases operational strength and adaptability |
Market Dominance | Explore HCA Healthcare's position as the largest U.S. hospital operator, leveraging economies of scale and network effects to drive growth and efficiency |
Metrics to compare | HCA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHCAPeersSector | |
---|---|---|---|---|
P/E Ratio | 13.7x | 18.8x | −0.6x | |
PEG Ratio | 0.86 | −0.10 | 0.00 | |
Price / Book | −31.7x | 8.8x | 2.6x | |
Price / LTM Sales | 1.1x | 2.3x | 3.1x | |
Upside (Analyst Target) | 20.7% | 20.4% | 51.8% | |
Fair Value Upside | Unlock | 24.2% | 8.3% | Unlock |